APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $143,585,000 | +99.9% | 2,271,917 | +35.7% | 0.63% | +102.9% |
| Q1 2021 | $71,832,000 | +40.1% | 1,674,004 | +86.7% | 0.31% | +61.1% |
| Q4 2020 | $51,283,000 | +89.6% | 896,551 | 0.0% | 0.19% | +78.7% |
| Q3 2020 | $27,049,000 | -7.6% | 896,551 | 0.0% | 0.11% | -16.3% |
| Q2 2020 | $29,281,000 | +21.9% | 896,551 | 0.0% | 0.13% | -12.8% |
| Q1 2020 | $24,019,000 | +57.8% | 896,551 | +80.4% | 0.15% | +82.7% |
| Q4 2019 | $15,217,000 | +101.3% | 496,969 | +58.4% | 0.08% | +58.8% |
| Q3 2019 | $7,558,000 | -4.9% | 313,725 | 0.0% | 0.05% | -5.6% |
| Q2 2019 | $7,950,000 | +29.9% | 313,725 | 0.0% | 0.05% | +38.5% |
| Q1 2019 | $6,118,000 | +136.6% | 313,725 | +60.0% | 0.04% | +85.7% |
| Q4 2018 | $2,586,000 | -25.8% | 196,078 | 0.0% | 0.02% | -8.7% |
| Q3 2018 | $3,486,000 | -19.2% | 196,078 | 0.0% | 0.02% | -28.1% |
| Q2 2018 | $4,314,000 | – | 196,078 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |